On ECHEMI
Home > Drugs > Chengdu Qingshan Likang Pharmaceutical Co., Ltd.
Chengdu Qingshan Likang Pharmaceutical Co., Ltd.
  • Founded in:

    2001-11-30
  • Country:

    China China
  • Address:

    No. 14, Gaopeng Avenue, Chengdu Hi-tech Zone
  • Tax NO.:

    91510100732384126D
  • Registered Funds:

    360 million yuan
  • Website:

  • Email:

Related Drugs
Hydroxyglycerin eye drops
Hydroxypropyl methylcellulose, dextran, glycerin.
Name Description Content CAS NO. Registered Holders
Hydroxypropyl methyl cellulose

No relevant information yet.

More

No relevant information yet.

9004-65-3 57
Dextran

No relevant information yet.

More

No relevant information yet.

9004-54-0 16
Glycerol

No relevant information yet.

More

No relevant information yet.

56-81-5 62
Peritoneal dialysis fluid (lactate-G4.25%)
This product is a compound preparation.
Name Description Content CAS NO. Registered Holders
SODIUM ION

Through the difference in solute concentration gradient, uremic substances in the blood can be removed from the dialysate, and electrolyte and acid-base balance can be maintained, replacing some of the functions of the kidneys.

More

Through the difference in solute concentration gradient, uremic substances in the blood can be removed from the dialysate, and electrolyte and acid-base balance can be maintained, replacing some of the functions of the kidneys.

132mmol/L 17341-25-2 0
Glucose and Sodium Chloride Injection
This product is a compound preparation containing glucose and sodium chloride.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Glucose is one of the main sources of calories for the human body

More

Glucose is one of the main sources of calories for the human body

58367-01-4 15
Sodium chloride

Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

More

Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

7647-14-5 43
Ofloxacin Eye Drops
Ofloxacin
Name Description Content CAS NO. Registered Holders
Ofloxacin

A broad-spectrum antibacterial drug, also effective against Chlamydia trachomatis. Mainly used to treat bacterial external eye infections, trachoma and bacterial intraocular infections.

More

A broad-spectrum antibacterial drug, also effective against Chlamydia trachomatis. Mainly used to treat bacterial external eye infections, trachoma and bacterial intraocular infections.

82419-36-1 30
Dexamethasone sodium phosphate eye drops
The main ingredients of this product and its chemical name: The main ingredient of this product is dexamethasone sodium phosphate. Its chemical name is: 16alpha;-methyl-11beta;,17alpha;,21-trihydroxy-9alpha;-fluoropregnane-1,4-diene-3,20-dione-21-phosphate disodium salt. Its molecular formula: C22H28FNa2O8P, molecular weight: 516.41.
Name Description Content CAS NO. Registered Holders
Dexamethasone sodium phosphate

It has multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive. Its main mechanisms are: 1. Anti-inflammatory effect: Glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the manifestation of inflammation. 2. Anti-allergic and immunosuppressive effects: prevent or inhibit cell-mediated immune responses, delay allergic reactions, and reduce the expansion of primary immune responses.

More

It has multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive. Its main mechanisms are: 1. Anti-inflammatory effect: Glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the manifestation of inflammation. 2. Anti-allergic and immunosuppressive effects: prevent or inhibit cell-mediated immune responses, delay allergic reactions, and reduce the expansion of primary immune responses.

55203-24-2 25
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.